Search Results - "LILLEYMAN, J"

Refine Results
  1. 1

    Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial by Mitchell, C. D., Richards, S. M., Kinsey, S. E., Lilleyman, J., Vora, A., Eden, T. O. B.

    Published in British journal of haematology (01-06-2005)
    “…Summary Corticosteroids are an essential component of treatment for acute lymphoblastic leukaemia (ALL). Prednisolone is the most commonly used steroid,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia by Lilleyman, J S, Lennard, L

    Published in The Lancet (British edition) (14-05-1994)
    “…Many months' treatment with daily oral mercaptopurine is an important part of therapy for nearly all children with lymphoblastic leukaemia (ALL). Even when…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997 by EDEN, O. B, HARRISON, G, RICHARDS, S, LILLEYMAN, J. S, BAILEY, C. C, CHESSELLS, J. M, HANN, I. M, HILL, F. G. H, GIBSON, B. E. S

    Published in Leukemia (01-12-2000)
    “…Results of three consecutive completed UK trials (1980-1997) for childhood lymphoblastic leukaemia are presented. National accrual has progressively increased…”
    Get full text
    Journal Article
  6. 6

    Human thiopurine methyltransferase activity varies with red blood cell age by Lennard, L., Chew, T. S., Lilleyman, J. S.

    Published in British journal of clinical pharmacology (01-11-2001)
    “…Aims  Inherited differences in thiopurine methyltransferase (TPMT) activity are an important factor in the wide interindividual variations observed in the…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia by LANCASTER, D. L, PATEL, N, LENNARD, L, LILLEYMAN, J. S

    Published in Cancer chemotherapy and pharmacology (01-07-2002)
    “…The aim of this study was to compare leucocyte and erythrocyte thioguanine nucleotide (TGN) cytotoxic metabolite concentrations in children with lymphoblastic…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Progressive reduction in treatment‐related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI) by Hargrave, D. R., Hann, I. M., Richards, S. M., Hill, F. G., Lilleyman, J. S., Kinsey, S., Bailey, C. C., Chessells, J. M., Mitchell, C., Eden, O. B.

    Published in British journal of haematology (01-02-2001)
    “…In the last 20 years, the survival rate for children with acute lymphoblastic leukaemia (ALL) has markedly improved, largely owing to a decrease in relapses…”
    Get full text
    Journal Article
  10. 10

    Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia by Lennard, L, Gibson, B E, Nicole, T, Lilleyman, J S

    Published in Archives of disease in childhood (01-11-1993)
    “…Two children with acute lymphoblastic leukaemia (ALL) taking daily 6-mercaptopurine as part of a national UK therapeutic trial repeatedly developed profound…”
    Get full text
    Journal Article
  11. 11

    Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia by Lennard, L, Lilleyman, J S

    Published in Journal of clinical oncology (01-12-1989)
    “…Intracellular thioguanine nucleotides (6-TGN) are the major cytotoxic metabolites of mercaptopurine (6-MP). Red blood cell (RBC) 6-TGN concentrations were…”
    Get more information
    Journal Article
  12. 12

    Profile of non-compliance in lymphoblastic leukaemia by Lancaster, D, Lennard, L, Lilleyman, J S

    Published in Archives of disease in childhood (01-04-1997)
    “…A nationwide study of intracellular drug metabolite concentrations in children prescribed 6-mercaptopurine for the treatment of lymphoblastic leukaemia was…”
    Get full text
    Journal Article
  13. 13

    Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia by Lennard, L, Lilleyman, J S, Van Loon, J, Weinshilboum, R M

    Published in The Lancet (British edition) (28-07-1990)
    “…6-mercaptopurine (6-MP) can be inactivated by S-methylation, which is catalysed by thiopurine methyltransferase (TPMT). An alternative metabolic route leads to…”
    Get more information
    Journal Article
  14. 14

    Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity by Lennard, L., Welch, J. C., Lilleyman, J. S.

    Published in British journal of clinical pharmacology (01-11-1997)
    “…Aims The response to 6‐mercaptopurine (6MP) is highly variable. Its antileukaemic effect can be related to drug derived 6‐thioguanine nucleotides (TGNs). The…”
    Get full text
    Journal Article
  15. 15

    6‐Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6‐thioguanine nucleotide concentrations by Lancaster, D. L., Patel, N., Lennard, L., Lilleyman, J. S.

    Published in British journal of clinical pharmacology (01-06-2001)
    “…Aims  Since relatively little is known about the pharmacokinetics of 6‐thioguanine (6TG) in children receiving 6‐thioguanine for maintenance therapy of acute…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Implementing the district hospital recommendations for the National Health Service Research Ethics Service in England by Wisely, J, Lilleyman, J

    Published in Journal of medical ethics (01-03-2007)
    “…[...]these views are not as incompatible as they might first appear…”
    Get full text
    Journal Article
  18. 18

    Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance? by LENNARD, L, WELCH, J, LILLEYMAN, J. S

    Published in British journal of cancer (01-10-1995)
    “…As part of a programme assessing the pharmacokinetics of oral thiopurines given for lymphoblastic leukaemia, we assayed intracellular metabolites of…”
    Get full text
    Journal Article
  19. 19

    Benefit of intensified treatment for all children with acute lymphoblastic leukaemia : results from MRC UKALL XI and MRC ALL97 randomised trials by HANN, I, VORA, A, RICHARDS, S, HILL, F, GIBSON, B, LILLEYMAN, J, KINSEY, S, MITCHELL, C, EDEN, O. B

    Published in Leukemia (01-03-2000)
    “…Treatment of children with acute lymphoblastic leukaemia (ALL) aims to cure all patients with as little toxicity as possible and, if possible, to restrict…”
    Get full text
    Journal Article
  20. 20

    Reflecting on Redfern: What can we learn from the Alder Hey story? by HALL, DAVID

    Published in Archives of disease in childhood (01-06-2001)
    “…In 1998 the General Medical Council (GMC) charged two Bristol surgeons and their medical director with misconduct on the grounds that they had failed to…”
    Get full text
    Journal Article